Home Careers Contact

Price: 3.15

Change: 0.00

Day High: 3.20
Day Low: 3.10
Volume: 548,047

4:00 PM ET | Sep 25, 2017
Delayed 20 min., by eSignal.

Shareholder Tools

Investor Relations

Cempra, Inc. is a clinical-stage pharmaceutical company focused on developing antibacterials to meet critical medical needs. Two lead antibacterial products, both in the treatment of infectious diseases, address the urgent and increasing need for new treatments targeting drug-resistant bacterial infections in both the hospital and the community.

View all »Events & Presentations

Sep 26, 2017
Ladenburg Thalmann 2017 Healthcare Conference